When does Pfizer report earnings and how will it affect PFE stock?

Pfizer reports on **03 Feb 2026 at 08:30 EST**. The print will affect PFE stock through guidance, Comirnaty and Paxlovid revenue, and margin commentary. Strong guidance could lift shares; weak guidance could pressure them.

What valuation metrics should investors watch for PFE stock?

Watch **PE 15.37**, price-to-sales **2.40**, dividend yield **6.50%**, and payout ratio **0.99**. These metrics show income appeal but limited earnings growth, which matters for PFE stock positioning.

What is Meyka AI's grade and what does it mean for PFE stock?

Meyka AI rates PFE with a score out of 100 at **69.95** (Grade **B**, Suggestion: **HOLD**). The grade blends benchmark, sector, growth, metrics, and analyst consensus and is informational, not investment advice.

What price targets should investors consider for PFE stock?

Consider a **$28.00** bull target (+5.91%), a **$24.00** base target (-9.23%), and a **$21.00** bear target (-20.58%). Use targets with risk controls and updated earnings data.

US Stocks

PFE Pfizer Inc. (NYSE) Pre-market 02 Feb 2026: Earnings tomorrow, guidance focus

ByHuzaifa Zahoor February 2, 2026

PFE stock trades at $26.44 in US pre-market on the NYSE as investors position ahead of Pfizer Inc.’s earnings due 03 Feb 2026. Volume is active at 51,599,439 shares versus a 50-day average of 25.45 and a 200-day average of 24.60. Key metrics show EPS $1.72 and PE 15.37, with a market cap of $150.27B. This earnings spotlight focuses on guidance risk, revenue drivers like Comirnaty and Paxlovid, and what numbers could move PFE stock at the open